EPLINα controls integrin recycling from Rab21 endosomes to drive breast cancer cell migration

Niklas Z. Jäntti; Paulina Moreno-Layseca; Megan R. Chastney; Michal Dibus; James R.W. Conway; Veli Matti Leppänen; Hellyeh Hamidi; Kathrin Eylmann; Leticia Oliveira-Ferrer; Stefan Veltel; Johanna Ivaska

doi:10.1016/j.devcel.2025.06.025

EPLINα controls integrin recycling from Rab21 endosomes to drive breast cancer cell migration

Niklas Z. Jäntti
, Paulina Moreno-Layseca^*
, Megan R. Chastney
, Michal Dibus
, James R.W. Conway
, Veli Matti Leppänen
, Hellyeh Hamidi
, Kathrin Eylmann
, Leticia Oliveira-Ferrer
, Stefan Veltel
, Johanna Ivaska^*

^*Korresponderande författare för detta arbete

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

7 Citeringar (Scopus)

14 Nedladdningar (Pure)

Sammanfattning

Epithelial protein lost in neoplasm (EPLIN), an actin-binding protein, has been described as both a tumor promoter and tumor suppressor in different cancers. The roles of EPLIN isoforms (α/β) remain largely unknown and could explain these opposing views. We observed distinct EPLIN isoform localization in breast cancer cells; EPLINα is recruited to actin in plasma membrane ruffles and endosomes, while EPLINβ resides on stress fibers. EPLINα localizes to early endosomes in an actin-dependent manner, where it interacts with Rab21, an established regulator of β1-integrin endosomal trafficking. This supports β1-integrin recycling and cell migration. Using proximity biotinylation (BioID), we identified coronin 1C as an EPLIN-proximal protein, which also localizes at Rab21-containing endosomes and controls integrin recycling downstream of EPLINα. EPLINα expression was linked to increased breast cancer cell motility, and a high EPLINα-to-EPLINβ ratio correlated with a mesenchymal phenotype in patient samples. Our work identifies previously unknown EPLIN-isoform-specific functions relevant to breast cancer and beyond.

Originalspråk	Engelska
Sidor (från-till)	3018-3033.e7
Tidskrift	Developmental Cell
Volym	60
Nummer	22
DOI	https://doi.org/10.1016/j.devcel.2025.06.025
Status	Publicerad - 17 nov. 2025
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Finansiering

We thank P. Laasola and J. Siivonen for technical assistance and the Ivaska laboratory for critical reading of the manuscript and constructive feedback. We thank James Bear (University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA) for providing reagents. The Cell Imaging and cytometry core (Turku Bioscience Centre, University of Turku and Åbo Akademi University and Biocenter Finland) are acknowledged for services, instrumentation, and expertise. We also thank Christoffer Lagerholm for assistance with image acquisition. This work was supported by the Finnish Cancer Institute (K. Albin Johansson Professorship to J.I.), a Research Council of Finland project grant ( #325464 to J.I.) and Centre of Excellence program ( #346131 to J.I.), the Cancer Foundation Finland (J.I.), the Sigrid Juselius Foundation (J.I.), the Research Council of Finland’s Flagship InFLAMES (# 337530 and 357910 ), the Jane and Aatos Erkko Foundation (J.I.), and European Research Council advanced grant (# 101142305 ; Border Control). N.Z.J. was supported by the University of Turku Doctoral Programme in Technology, the Swedish Cultural Foundation in Finland , the Varsinais-Suomi Regional Fund , the K. Albin Johansson Foundation , and the Ida Montin Foundation . This study has been supported by the Research Council of Finland postdoctoral fellowships (grant nos. 321493 [to P.M.-L.], 338585 [to J.R.W.C], and 343239 [to M.R.C.]) and Research Fellowship (grant no. 360775 to J.R.W.C). J.R.W.C. was also supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (grant 841973 ). M.D. was supported by the European Union’s Horizon Europe research and innovation programme under Marie Sklodowska-Curie grant agreement no. 101108089 .

Nyckelord

EPLIN alpha
EPLIN interactome
breast cancer cells
cell migration
Rab21
actin
integrin recycling
endosomal transport
EPLIN isoforms

Åtkomst av dokument

10.1016/j.devcel.2025.06.025Licens: CC BY

PIIS1534580725004034Slutlig publicerad version, 16,8 MBLicens: CC BY

https://urn.fi/URN:NBN:fi-fe202601289477

Andra filer och länkar

Länk till publikationen i Scopus

Citera det här

@article{a8aa41b62c8c4def911512d357145ad9,

title = "EPLINα controls integrin recycling from Rab21 endosomes to drive breast cancer cell migration",

abstract = "Epithelial protein lost in neoplasm (EPLIN), an actin-binding protein, has been described as both a tumor promoter and tumor suppressor in different cancers. The roles of EPLIN isoforms (α/β) remain largely unknown and could explain these opposing views. We observed distinct EPLIN isoform localization in breast cancer cells; EPLINα is recruited to actin in plasma membrane ruffles and endosomes, while EPLINβ resides on stress fibers. EPLINα localizes to early endosomes in an actin-dependent manner, where it interacts with Rab21, an established regulator of β1-integrin endosomal trafficking. This supports β1-integrin recycling and cell migration. Using proximity biotinylation (BioID), we identified coronin 1C as an EPLIN-proximal protein, which also localizes at Rab21-containing endosomes and controls integrin recycling downstream of EPLINα. EPLINα expression was linked to increased breast cancer cell motility, and a high EPLINα-to-EPLINβ ratio correlated with a mesenchymal phenotype in patient samples. Our work identifies previously unknown EPLIN-isoform-specific functions relevant to breast cancer and beyond.",

keywords = "actin, breast cancer cells, cell migration, endosomal transport, EPLIN alpha, EPLIN interactome, EPLIN isoforms, integrin recycling, Rab21, EPLIN alpha, EPLIN interactome, breast cancer cells, cell migration, Rab21, actin, integrin recycling, endosomal transport, EPLIN isoforms",

author = "J{\"a}ntti, \{Niklas Z.\} and Paulina Moreno-Layseca and Chastney, \{Megan R.\} and Michal Dibus and Conway, \{James R.W.\} and Lepp{\"a}nen, \{Veli Matti\} and Hellyeh Hamidi and Kathrin Eylmann and Leticia Oliveira-Ferrer and Stefan Veltel and Johanna Ivaska",

note = "Publisher Copyright: {\textcopyright} 2025 The Author(s).",

year = "2025",

month = nov,

day = "17",

doi = "10.1016/j.devcel.2025.06.025",

language = "English",

volume = "60",

pages = "3018--3033.e7",

journal = "Developmental Cell",

issn = "1534-5807",

publisher = "Elsevier",

number = "22",

}

TY - JOUR

T1 - EPLINα controls integrin recycling from Rab21 endosomes to drive breast cancer cell migration

AU - Jäntti, Niklas Z.

AU - Moreno-Layseca, Paulina

AU - Chastney, Megan R.

AU - Dibus, Michal

AU - Conway, James R.W.

AU - Leppänen, Veli Matti

AU - Hamidi, Hellyeh

AU - Eylmann, Kathrin

AU - Oliveira-Ferrer, Leticia

AU - Veltel, Stefan

AU - Ivaska, Johanna

PY - 2025/11/17

Y1 - 2025/11/17

N2 - Epithelial protein lost in neoplasm (EPLIN), an actin-binding protein, has been described as both a tumor promoter and tumor suppressor in different cancers. The roles of EPLIN isoforms (α/β) remain largely unknown and could explain these opposing views. We observed distinct EPLIN isoform localization in breast cancer cells; EPLINα is recruited to actin in plasma membrane ruffles and endosomes, while EPLINβ resides on stress fibers. EPLINα localizes to early endosomes in an actin-dependent manner, where it interacts with Rab21, an established regulator of β1-integrin endosomal trafficking. This supports β1-integrin recycling and cell migration. Using proximity biotinylation (BioID), we identified coronin 1C as an EPLIN-proximal protein, which also localizes at Rab21-containing endosomes and controls integrin recycling downstream of EPLINα. EPLINα expression was linked to increased breast cancer cell motility, and a high EPLINα-to-EPLINβ ratio correlated with a mesenchymal phenotype in patient samples. Our work identifies previously unknown EPLIN-isoform-specific functions relevant to breast cancer and beyond.

AB - Epithelial protein lost in neoplasm (EPLIN), an actin-binding protein, has been described as both a tumor promoter and tumor suppressor in different cancers. The roles of EPLIN isoforms (α/β) remain largely unknown and could explain these opposing views. We observed distinct EPLIN isoform localization in breast cancer cells; EPLINα is recruited to actin in plasma membrane ruffles and endosomes, while EPLINβ resides on stress fibers. EPLINα localizes to early endosomes in an actin-dependent manner, where it interacts with Rab21, an established regulator of β1-integrin endosomal trafficking. This supports β1-integrin recycling and cell migration. Using proximity biotinylation (BioID), we identified coronin 1C as an EPLIN-proximal protein, which also localizes at Rab21-containing endosomes and controls integrin recycling downstream of EPLINα. EPLINα expression was linked to increased breast cancer cell motility, and a high EPLINα-to-EPLINβ ratio correlated with a mesenchymal phenotype in patient samples. Our work identifies previously unknown EPLIN-isoform-specific functions relevant to breast cancer and beyond.

KW - actin

KW - breast cancer cells

KW - cell migration

KW - endosomal transport

KW - EPLIN alpha

KW - EPLIN interactome

KW - EPLIN isoforms

KW - integrin recycling

KW - Rab21

KW - EPLIN alpha

KW - EPLIN interactome

KW - breast cancer cells

KW - cell migration

KW - Rab21

KW - actin

KW - integrin recycling

KW - endosomal transport

KW - EPLIN isoforms

UR - https://www.scopus.com/pages/publications/105010681322

U2 - 10.1016/j.devcel.2025.06.025

DO - 10.1016/j.devcel.2025.06.025

M3 - Article

C2 - 40669465

AN - SCOPUS:105010681322

SN - 1534-5807

VL - 60

SP - 3018-3033.e7

JO - Developmental Cell

JF - Developmental Cell

IS - 22

ER -

EPLINα controls integrin recycling from Rab21 endosomes to drive breast cancer cell migration

Sammanfattning

Finansiering

Nyckelord

Åtkomst av dokument

Andra filer och länkar

Fingeravtryck

Citera det här